Oncology in the Time of COVID

The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.

Ipsos white paper - Oncology in the Time of COVID: Assessing the impact of the COVID-19 pandemic on the indian oncology marketCancer patients in particular experienced impacts to many aspects of their care – two years on we reflect on specific effects seen in the Indian oncology market and how we believe a promising new upturn is taking shape.

In this paper, we combine data from three Ipsos studies conducted in India with our current therapy expertise and market insight, to outline how the COVID-19 pandemic influenced drug-treated cancer patient estimates, oncology drug revenue estimates and patient caseload management.

We also offer a forward-looking perspective on how we believe new healthcare initiatives put in place in this region may alleviate the effects of the pandemic and the future cancer treatment landscape.

Download

More insights about Health

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?